Global Gastric Cancer Market Report: 2016 Edition - New Report by Koncept Analytics

1
Global Gastric Cancer Market Report
----------------------------------------- 2016
View Report Details
2
View Report Details

• Executive Summary
• Cancer is a condition where an error or mutation
  in the cells DNA occurs, causing it to grow at a
  rapid rate. A cancer cell continues living while
  a normal cell would die, thus, accumulating to
  form a tumor that can break off and spread
  throughout the body. Gastric cancer is when such
  a condition occurs in the stomach and has the
  tendency to grow through the wall of the stomach
  to invade nearby organs including lymph nodes and
  lymph vessels. There are four types of cancers of
  the stomach namely, Adenocarcinoma, Lymphoma,
  Gastrointestinal stromal tumor (GIST), Carcinoid
  tumor and others such as squamous cell carcinoma,
  small cell carcinoma, and leiomyosarcomat that
  can start in the stomach, but are very rare.
• The causes of stomach cancer are rather unclear
  in medical study however, there is a strong
  correlation between a diet high in smoked, salted
  and pickled foods, obesity and ageing. People
  with Helicobacter infections are also highly
  prone to gastric cancer. Symptoms of gastric
  cancer may include, fatigue, feeling bloated
  after eating, severe heartburn and indigestion,
  stomach pain, persistent and unexplained
  vomiting and nausea, unintentional weight loss,
  belching, anemia, and persistent ulcer. Its
  medical diagnosis techniques involve upper
  endoscopy, imaging tests and exploratory surgery.
  Treatment options include surgery, chemotherapy,
  radiotherapy and targeted therapy.
• Global gastric cancer market is conspicuous by
  poor prognosis, because of the indolent nature of
  the disease. However, better diagnostic
  technology and shifting treatment market from
  chemotherapy to targeted therapies is expected to
  warrant positive growth in the years ahead.
  Rising oncology drug spending, ageing population,
  increasing obese population and rising global
  male population are expected to drive this
  growth. Certain trends in the global gastric
  cancer market include, a healthy pipeline of
  combinations targeted therapies, shifting focus
  towards molecular targeted therapies, and keen
  interest in eradication H. Pylori infection
  across the globe. The market is however,
  afflicted by certain challenges like low
  penetration of new targeted therapies and lack of
  reimbursement of cancer drugs.
• The report provides an overview of the entire
  market through global and regional analysis.
  Prevalence and market value of gastric cancer
  across the globe and that of its various types
  and stages including advanced, her2 positive,
  stage III and metastatic gastric cancer have been
  analyzed.

3
Global gastric cancer market is expected to
witness positive growth in the years ahead driven
by increasing smoking habits, obesity, ageing
population and rising spending on oncological
drugs worldwide
Global Gastric Cancer Market by Prevalence
(2015-2020E)

• The number of gastric cancer cases in 2015
  totaled thousand and is expected to increase to
  thousand in 2016.
• The global advanced gastric cancer market reached
  US...billion in the year 2015, and is estimated
  to reach US...billion by 2020.
• The market for advanced gastric cancer in the
  United States reached US...billion in 2015, and
  is expected to increase to US...billion in year
  2016.
• The prevalence of advanced gastric cancer in the
  United States totaled thousand of the
  population in 2015.
• In 2015, prevalence of metastatic gastric cancer
  in the United States totaled thousand, and is
  expected to rise to thousands in the current
  year.

Global Advanced Gastric Cancer Market by Value
(2015-2020E)
The U.S. Advanced Gastric Cancer Market by Value
(2015-2020E)
4
Global gastric cancer market is conspicuous by
poor prognosis, because of the indolent nature of
the disease

• The number of patients with gastric cancer in the
  U.S. reached thousands in the year 2015, and is
  estimated to incline to thousand in year 2016.
• In 2015, gastric cancer prevalence in EU5
  (France, Germany, Italy, Spain and the UK)
  totaled thousand of the population, and is
  expected to reach thousand in the year 2016.
• Advanced gastric cancer prevalence in the EU5
  reached thousand in year 2015.
• In 2015, patient prevalence in Japan totaled
  thousand. Incidence of gastric cancer has seen a
  decreasing trend in Japan and is expected to
  sustain in the years to come, declining to an
  estimated thousand in 2016.
• In 2015, the market for advanced gastric cancer
  in Japan reached billion, and is expected to
  increase to US... billion in the year 2016.

The U.S. Gastric Cancer Market by Prevalence
(2015-2020E)
The EU5 Gastric Cancer Market by Prevalence
(2015-2020E)
Japan Gastric Cancer Market by Prevalence
(2015E-2020E)
5
Better diagnostic technology and shifting
treatment market from chemotherapy to targeted
therapies is expected to warrant positive growth
in the years ahead
Combination Regimen Launches in Oncology
(2014-2020E)

• In 2015, the highest number of combinations
  regimen launches in oncology was expected to be
  .., while highest numbers of launches are
  expected to be .. in the year 2019.
• In 2015, global spending on targeted therapies is
  expected to have reached US... billion,
  increasing from US... billion in the previous
  fiscal year.
• In 2015, the global spending on oncology drugs is
  estimated to have reached US... billion, with
  the U.S. and the EU5 accounting for a major share
  amounting to US... billion and US... billion
  respectively.
• The share of certain countries emerging in the
  pharmaceutical market, or pharmerging
  countries, is expected to reach US... billion in
  the year 2015, witnessing a ... incline from the
  previous year.

Global Targeted Therapies Spending (2010-2015E)
Global Oncology Drug Spending by Region
(2010-2015E)
6
Contact Us
View Report Details
These are abridged and sanitized sample pages
from the comprehensive report on the Global
Gastric Cancer Market . To know more about this
report or for any customized research
requirement, please contact the following
Koncept Analytics CS-36, Second Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T.
91-120-4130959 C 91-9811715635
vikas_at_konceptanalytics.com
Vikas Gupta BD Manager
www.konceptanalytics.com